Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Effectiveness of lifestyle intervention in subgroups of obese infertile women: a subgroup analysis of a RCT.

van Oers AM, Groen H, Mutsaerts MA, Burggraaff JM, Kuchenbecker WK, Perquin DA, Koks CA, van Golde R, Kaaijk EM, Schierbeek JM, Oosterhuis GJ, Broekmans FJ, Vogel NE, Land JA, Mol BW, Hoek A; LIFEstyle study group ..

Hum Reprod. 2017 Feb;32(2):482. doi: 10.1093/humrep/dew318. No abstract available.

PMID:
27989990
2.

Effectiveness of lifestyle intervention in subgroups of obese infertile women: a subgroup analysis of a RCT.

van Oers AM, Groen H, Mutsaerts MA, Burggraaff JM, Kuchenbecker WK, Perquin DA, Koks CA, van Golde R, Kaaijk EM, Schierbeek JM, Oosterhuis GJ, Broekmans FJ, Vogel NE, Land JA, Mol BW, Hoek A; LIFEstyle study group..

Hum Reprod. 2016 Dec;31(12):2704-2713. Erratum in: Hum Reprod. 2017 Feb;32(2):482.

PMID:
27798042
3.

Randomized Trial of a Lifestyle Program in Obese Infertile Women.

Mutsaerts MA, van Oers AM, Groen H, Burggraaff JM, Kuchenbecker WK, Perquin DA, Koks CA, van Golde R, Kaaijk EM, Schierbeek JM, Oosterhuis GJ, Broekmans FJ, Bemelmans WJ, Lambalk CB, Verberg MF, van der Veen F, Klijn NF, Mercelina PE, van Kasteren YM, Nap AW, Brinkhuis EA, Vogel NE, Mulder RJ, Gondrie ET, de Bruin JP, Sikkema JM, de Greef MH, ter Bogt NC, Land JA, Mol BW, Hoek A.

N Engl J Med. 2016 May 19;374(20):1942-53. doi: 10.1056/NEJMoa1505297.

4.

Evaluation of strategies regarding management of imminent preterm delivery before 32 weeks of gestation: a regional cohort study among 1375 women in the Netherlands.

Boesveld M, Oudijk MA, Koenen SV, Brouwers HA, Van Beek E, Boon J, Drogtrop A, Euser R, Evers IM, Fiedeldeij CA, Heida KY, Huisjes AJ, Muijsers GJ, Schierbeek JM, Kwee A.

Am J Obstet Gynecol. 2015 Mar;212(3):348.e1-7. doi: 10.1016/j.ajog.2014.10.014.

PMID:
25447962
5.

The LIFESTYLE study: costs and effects of a structured lifestyle program in overweight and obese subfertile women to reduce the need for fertility treatment and improve reproductive outcome. A randomised controlled trial.

Mutsaerts MA, Groen H, ter Bogt NC, Bolster JH, Land JA, Bemelmans WJ, Kuchenbecker WK, Hompes PG, Macklon NS, Stolk RP, van der Veen F, Maas JW, Klijn NF, Kaaijk EM, Oosterhuis GJ, Bouckaert PX, Schierbeek JM, van Kasteren YM, Nap AW, Broekmans FJ, Brinkhuis EA, Koks CA, Burggraaff JM, Blankhart AS, Perquin DA, Gerards MH, Mulder RJ, Gondrie ET, Mol BW, Hoek A.

BMC Womens Health. 2010 Jun 25;10:22. doi: 10.1186/1472-6874-10-22.

6.

Efficacy and tolerability of a new estradiol delivering matrix patch (Estraderm MX) in postmenopausal women.

de Vrijer B, Snijders MP, Troostwijk AL, Thé S, Iding RJ, Friese S, Smit DA, Schierbeek JM, Brandts H, van Kempen PJ, van Buuren I, Monza G.

Maturitas. 2000 Jan 15;34(1):47-55.

PMID:
10687882
7.

A unique case of holoprosencephaly.

Potters AE, Schierbeek JM, Jansen W.

Prenat Diagn. 1996 Oct;16(10):950-3.

PMID:
8938068

Supplemental Content

Loading ...
Support Center